Advertisement
YOU ARE HERE: LAT HomeCollections

IN BRIEF / PHARMACEUTICALS

Chiron to Buy Vaccine Maker PowderJect

May 20, 2003|From Associated Press

As expected, Chiron Corp. said it would buy its British rival, PowderJect Pharmaceuticals, for about $878 million, increasing the biotech company's share of the growing market for vaccines.

The cash deal would give Emeryville, Calif.-based Chiron control of Fluvirin, a top-selling flu vaccine.

Chiron's shares fell 80 cents to $40.25 on Nasdaq.

Advertisement
Los Angeles Times Articles
|
|
|